Chlorpheniramine Maleate (CTM) is an alkylamine derivative and antihistamine. It
has a relatively short half-life and requires frequent administration, approximately
four to six times per day. Ensuring patient convenience in drug consumption is
essential. Therefore, CTM was formulated into an Orally Disintegrating Film (ODF),
which can be administered without the need for water. This study aimed to formulate
CTM into an ODF dosage form using HPMC K4M as the polymer, glycerin as the
plasticizer, and stevioside as the sweetener. The ODF was prepared using the solvent
casting method. Four formulations were developed: F1 (2% HPMC K4M, 0.2%
glycerin), F2 (2% HPMC K4M, 0.6% glycerin), F3 (4% HPMC K4M, 0.4% glycerin),
and F4 (4% HPMC K4M, 1.2% glycerin). The pre-gel pH evaluation showed that all
formulations met the requirements, with a pH range of 5.743 ± 0.005 to 5.817 ± 0.011.
Organoleptic evaluation revealed that F1 and F2 formed whitish, wrinkled, and nonhomogeneous
films, whereas F3 formed a clear, non-wrinkled, and relatively
homogeneous film, and F4 formed a whitish, non-wrinkled, but non-homogeneous
film. The results of the thickness and weight evaluation were only F3 qualified, with
values of 0.075 ± 0.003 mm and 0.035 ± 0.001 g. Moisture content analysis showed
compliance with the required range of 15.49 ± 3.35% to 21.81 ± 1.39%. The
disintegration time met the requirement of being <60 seconds. The content uniformity
evaluation met the required specifications, with an average content of 97.33 ± 4.63%,
and an acceptance value of 12.28. Based on these results, F3 was determined to be the
optimal ODF formulation for CTM.
Keywords: Orally Disintegrating Film, Chlorpheniramine Maleate, Solvent casting,
HPMC, Stevioside